These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35085427)

  • 21. Predicting protein and pathway associations for understudied dark kinases using pattern-constrained knowledge graph embedding.
    Salcedo MV; Gravel N; Keshavarzi A; Huang LC; Kochut KJ; Kannan N
    PeerJ; 2023; 11():e15815. PubMed ID: 37868056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Learned Embeddings from Deep Learning to Visualize and Predict Protein Sets.
    Dallago C; Schütze K; Heinzinger M; Olenyi T; Littmann M; Lu AX; Yang KK; Min S; Yoon S; Morton JT; Rost B
    Curr Protoc; 2021 May; 1(5):e113. PubMed ID: 33961736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. REDIAL-2020: A suite of machine learning models to estimate Anti-SARS-CoV-2 activities.
    Govinda KC; Bocci G; Verma S; Hassan M; Holmes J; Yang JJ; Sirimulla S; Oprea TI
    ChemRxiv; 2020 Sep; ():. PubMed ID: 33200119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the dark genome: implications for precision medicine.
    Oprea TI
    Mamm Genome; 2019 Aug; 30(7-8):192-200. PubMed ID: 31270560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring Chemical Information in PubChem.
    Kim S
    Curr Protoc; 2021 Aug; 1(8):e217. PubMed ID: 34370395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVIDpro: Database for mining protein dysregulation in patients with COVID-19.
    Zhang F; Luna A; Tan T; Chen Y; Sander C; Guo T
    bioRxiv; 2022 Sep; ():. PubMed ID: 36203550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring Manually Curated Annotations of Intrinsically Disordered Proteins with DisProt.
    Quaglia F; Hatos A; Salladini E; Piovesan D; Tosatto SCE
    Curr Protoc; 2022 Jul; 2(7):e484. PubMed ID: 35789137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell™.
    Kumar N; Golhar R; Sharma KS; Holloway JL; Sarangi S; Neuhaus I; Walsh AM; Pitluk ZW
    BMC Genomics; 2021 Jan; 22(1):5. PubMed ID: 33407110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring FlyBase Data Using QuickSearch.
    Marygold SJ;
    Curr Protoc; 2023 Apr; 3(4):e731. PubMed ID: 37014762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Multiplex One-Step RT-qPCR Protocol to Detect SARS-CoV-2 in NP/OP Swabs and Saliva.
    Bland J; Kavanaugh A; Hong LK; Perez O; Kadkol SS
    Curr Protoc; 2021 May; 1(5):e145. PubMed ID: 34004070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Druggable cancer secretome: neoplasm-associated traits.
    Narayanan R
    Cancer Genomics Proteomics; 2015; 12(3):119-31. PubMed ID: 25977171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.
    Subbarayan K; Ulagappan K; Wickenhauser C; Bachmann M; Seliger B
    Front Immunol; 2021; 12():597399. PubMed ID: 33796097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Illuminating the druggable genome: Pathways to progress.
    Sharma KR; Colvis CM; Rodgers GP; Sheeley DM
    Drug Discov Today; 2024 Mar; 29(3):103805. PubMed ID: 37890715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CoV-Seq, a New Tool for SARS-CoV-2 Genome Analysis and Visualization: Development and Usability Study.
    Liu B; Liu K; Zhang H; Zhang L; Bian Y; Huang L
    J Med Internet Res; 2020 Oct; 22(10):e22299. PubMed ID: 32931441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial Disease Sequence Data Resource (MSeqDR): a global grass-roots consortium to facilitate deposition, curation, annotation, and integrated analysis of genomic data for the mitochondrial disease clinical and research communities.
    Falk MJ; Shen L; Gonzalez M; Leipzig J; Lott MT; Stassen AP; Diroma MA; Navarro-Gomez D; Yeske P; Bai R; Boles RG; Brilhante V; Ralph D; DaRe JT; Shelton R; Terry SF; Zhang Z; Copeland WC; van Oven M; Prokisch H; Wallace DC; Attimonelli M; Krotoski D; Zuchner S; Gai X; ; ; ; ; ;
    Mol Genet Metab; 2015 Mar; 114(3):388-96. PubMed ID: 25542617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis.
    Chong J; Wishart DS; Xia J
    Curr Protoc Bioinformatics; 2019 Dec; 68(1):e86. PubMed ID: 31756036
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.